Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BAY1214784 in Healthy Postmenopausal Women
NCT02212080Phase 1Completed
- Sponsor
- Bayer
- Start
- Sep 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Uterine Fibroids (UF) comparing BAY1214784 with Placebo (2 arms). Primary endpoints: Number of adverse events and Severity of adverse events. Started Sep 2014; status: completed.
02
Drugs
BAY 1214784
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT02212080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212080.